Tenax Therapeutics, INC. (TENX) SEC Filings — 2024
37 SEC filings for Tenax Therapeutics, INC. (TENX) in 2024.
Filings
- Tenax Therapeutics Announces Director and Officer Changes — 8-K · Dec 4, 2024
- Tenax Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Tenax Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Tenax Therapeutics, INC. SC 13G Filing — SC 13G · Nov 14, 2024
- Tenax Therapeutics Q3 2024 Update — 10-Q · Nov 13, 2024
- Tenax Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 13, 2024
- Tenax Therapeutics, INC. SC 13G Filing — SC 13G · Nov 12, 2024
- Tenax Therapeutics Announces Director Changes and Stockholder Meeting — 8-K · Oct 30, 2024
- Tenax Therapeutics Files Proxy Statement for Annual Meeting — DEF 14A · Sep 27, 2024
- Tenax Therapeutics, INC. SC 13G Filing — SC 13G · Sep 10, 2024
- Tenax Therapeutics, INC. SC 13G Filing — SC 13G · Aug 19, 2024
- Tenax Therapeutics, INC. SC 13G Filing — SC 13G · Aug 19, 2024
- Tenax Therapeutics, INC. SC 13G Filing — SC 13G · Aug 15, 2024
- Tenax Therapeutics, INC. SC 13G Filing — SC 13G · Aug 14, 2024
- Tenax Therapeutics, INC. SC 13G Filing — SC 13G · Aug 14, 2024
- Tenax Therapeutics Reports Q2 Loss, Announces Private Placement — 10-Q · Aug 13, 2024
- Tenax Therapeutics Files 8-K Report — 8-K · Aug 12, 2024
- Tenax Therapeutics Files 8-K for Financial Statements — 8-K · Aug 6, 2024
- Tenax Therapeutics Appoints New Officers, Elects Directors — 8-K · Jun 13, 2024
- Tenax Therapeutics Files Proxy Materials — DEFA14A · May 24, 2024
- Tenax Therapeutics Q1 2024: Assets and Liabilities — 10-Q · May 14, 2024
- Tenax Therapeutics, Inc. Announces Annual Meeting of Stockholders on June 7, 2024 — DEF 14A · Apr 26, 2024
- Tenax Therapeutics Files 8-K on Financials — 8-K · Mar 28, 2024
- Tenax Therapeutics Files 8-K on Feb 22nd Event — 8-K · Feb 23, 2024
- Tenax Therapeutics Enters Material Definitive Agreement — 8-K · Feb 20, 2024
- Tenax Therapeutics, INC. SC 13G Filing — SC 13G · Feb 20, 2024
- Tenax Therapeutics, INC. SC 13G Filing — SC 13G · Feb 16, 2024
- Tenax Therapeutics, INC. SC 13G Filing — SC 13G · Feb 15, 2024
- Tenax Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- TENAX THERAPEUTICS FILES 8-K ON MATERIAL AGREEMENT; DETAILS UNDISCLOSED — 8-K · Feb 12, 2024
- TENAX THERAPEUTICS FILES 8-K: ROUTINE 'OTHER EVENTS' DISCLOSURE — 8-K · Feb 8, 2024
- Tenax Therapeutics Files 8-K on Feb 6, Confirms Nasdaq Listing — 8-K · Feb 6, 2024
- Tenax Therapeutics Files S-1/A Amendment for XBRL Exhibits — S-1/A · Feb 2, 2024
- Tenax Therapeutics, Inc. Files S-1/A Amendment — S-1/A · Feb 1, 2024
- Tenax Therapeutics Confirms Nasdaq Listing for Common Stock — 8-K · Jan 19, 2024
- TENAX THERAPEUTICS FACES NASDAQ DELISTING THREAT — 8-K · Jan 12, 2024
- TENAX THERAPEUTICS Reports Shareholder Rights, Bylaw Changes — 8-K · Jan 5, 2024